Metoprololo Eg

Metoprolol, the active ingredient in Metoprololo Eg, is a beta blocker presented as an oral dosage form for oral use. It is employed to manage hypertension, angina pectoris, heart failure and to improve outcomes after myocardial infarction. GNH USA supplies Metoprololo Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metoprolol acts on the cardiovascular system to control blood pressure and heart workload. Hypertension: lowers systemic blood pressure and reduces cardiovascular risk. Angina pectoris: decreases myocardial oxygen demand, relieving chest pain. Heart failure: improves ventricular function and reduces hospitalisation rates. Post‑myocardial infarction: lowers the risk of recurrent cardiac events and mortality.

Metoprolol may cause a range of adverse reactions, most of which are dose‑related and reversible upon discontinuation.

Common Side Effects: - Fatigue or tiredness - Dizziness or light‑headedness - Cold extremities or peripheral vasoconstriction - Bradycardia (slow heart rate) - Gastrointestinal upset such as nausea or abdominal discomfort - Headache

Serious or Rare Side Effects: - Severe bradycardia or heart block - Marked hypotension - Exacerbation of heart failure - Bronchospasm in patients with reactive airway disease - Allergic reactions including rash or angioedema - Depression or mood changes

Metoprolol should be used with careful clinical assessment and monitoring. Cardiovascular assessment: evaluate heart rate and blood pressure before initiation. Respiratory conditions: avoid in patients with severe asthma or chronic obstructive pulmonary disease without specialist advice. Diabetes monitoring: monitor blood glucose as beta‑blockade may mask hypoglycaemia symptoms. Renal/hepatic impairment: dose adjustment may be required in reduced organ function. Concomitant drugs: review other medications that affect heart rate or blood pressure. Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Metoprolol can interact with several drug classes, altering its efficacy or safety profile.

Major Interactions (Avoid): - Verapamil or diltiazem: combined use may cause severe bradycardia or AV block. - Clonidine: abrupt discontinuation after beta‑blocker therapy can precipitate rebound hypertension. - Other beta‑blockers: additive negative chronotropic effects increase risk of heart block.

Moderate Interactions (Monitor Closely): - Diuretics: may enhance hypotensive response. - ACE inhibitors or ARBs: additive blood‑pressure lowering effect requires monitoring. - Antidiabetic agents: beta‑blockade can mask hypoglycaemia signs, necessitating glucose checks.